All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Fri 2018-12-07? to Tue 2024-12-31? | ||||||
---|---|---|---|---|---|---|
MRNA × | ||||||
Moderna Inc NASDAQ Common Stock | ||||||
Fri 2018-12-07? to Tue 2024-12-31? |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
MRNA × |
+78.37%
+10.01%/yr |
+27.21%/yr
(R2=0.230) |
||||
Moderna Inc NASDAQ Common Stock | ||||||
Fri 2018-12-07? to Tue 2024-12-31? |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
MRNA × |
$10,000.00
2018-12-07 |
$17,837.27
2024-12-31 |
||||
Moderna Inc NASDAQ Common Stock | ||||||
Year | MRNA |
---|---|
2025 (YTD) | −41.24% |
2024 | −59.36% |
2023 | −46.43% |
2022 | −33.57% |
2021 | +127.12% |
2020 | +427.00% |
2019 | +25.20% |
2018 | −17.71% |
Fri 2018-12-07? to Tue 2024-12-31? |
Final
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
MRNA × | −92.57% |
−93.42%
2024-11-15 |
||||
Moderna Inc NASDAQ Common Stock | ||||||